HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare's reaction to signs of potentially contaminated packaging for OTC products including Tylenol raised FDA's ire and is now costing the firm an extensive product recall

You may also be interested in...



J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics

Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.

St. Joseph Aspirin Is First J&J/McNeil Divestiture From 2010 OTC Recalls

Johnson & Johnson unloads St. Joseph Aspirin, an OTC brand that suffered a significant dip in sales following a 2010 recall due to contaminated packaging.

In Brief

Prestige Brands buys Dramamine

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel